Investor Relations

Vitro Diagnostics dba Vitro Biopharma develops and commercialize adult stem cell technology for applications in stem cell research, drug development and therapeutic products for treatment a vast variety of diseases and conditions. We offer a series of tools to promote the development of stem cell research and clinical applications focusing on Mesenchymal Stem Cells (MSCs).

Become an Investor: Call (303) 999-2137

Vitro Diagnostics, Inc. (OTCPK:VODG)

VODG 0,54 -0,01 -1,82%

Company Information

Vitro Biopharma

4621 Technology Drive

Golden, CO 80403

303-999-2130

www.vitrobiopharma.com

Investor Relations

John Evans

CFO & Director

john@vitrobiopharma.com

303-999-2137

wwww.vitrobiopharma.com

Transfer Agent

Securities Transfer Corporation

2591 Dallas Parkway, Suite 102

Frisco, TX 75034

469-633-0101

www.stctransfer.com

Share Statistics

Outstanding: 46,194,200

(As of June 26th, 2018)

Investor News

Providing high quality commercialized cell lines, media, stem cell products & stem cell technology

Providing applications in stem cell research, drug discovery and STEM CELL therapies

Customer Service (303)-999-2130 Ext. 1

4621 Technology Drive Golden, CO 80403

Technical Support (303)-999-2130 Ext. 2

info@vitrobiopharma.com

Accounting (303)-999-2130 Ext. 3

Please click the image above to view our ISO 13485:2016.

Please click the image above to view our ISO 9001:2015 Certification.

Please click the image above to view our FDA registration.